VELARU GALACTIC EXHIBIT PACK — SYNTHETIC BIOLOGY / BIOSECURITY Jurisdiction: Global / Multi-jurisdiction (global) Modality: Text / Chat Program: Velaru Mandate Registry — Synthetic Biology / Biosecurity (galactic_synthetic_biology) Product ID: synthetic_biology:global:bundle:text Vertical: synthetic_biology Generated: 2026-08-11T00:26:28.034377Z Authority: Global External Validation — Biosecurity AI Screening Pack Deadline: Federal Select Agent Program + DURC Velaru verify: https://velaru.onrender.com/verify EXHIBIT A — AI INVENTORY [] EXHIBIT B — GOVERNANCE FRAMEWORK { "framework": "Velaru Mandate Registry \u2014 Synthetic Biology / Biosecurity", "exhibit_authority": "Global External Validation \u2014 Biosecurity AI Screening Pack", "regulatory_frameworks": [ "Federal Select Agent Program", "NIH Guidelines", "DURC Policy", "ISO 42001", "NIST AI RMF 1.0", "OECD AI Principles" ], "standards_alignment": [ "POSS-2", "DRP-1", "TCB", "FRE 707 pre-compliance", "ISO 42001" ], "human_oversight": "synthesize DNA sequence", "third_party_verification": "https://velaru.onrender.com/verify (operator-independent)", "data_lineage": "Hash-chained Ed25519 receipts; optional RFC3161 + external anchor", "mirror_trap": "Cloud lab orders sequence \u2014 lab owns biosecurity violation, screening vendor owns API uptime SLA. \u00b7 Multinationals built for one jurisdiction fail exams in another \u2014 one receipt architecture, many filing packs.", "chain_integrity": { "depth": 39, "invariant_holds": true } } EXHIBIT D — DATA INPUTS & VALIDATION { "data_validation_method": "Cryptographic receipt per AI decision; public verify without trusting deployer, vendor, or Velaru operator", "bias_testing_proxy": "Asymmetry score from live chain signals", "model_change_control": "Policy lock registry \u2014 criteria hash frozen pre-dispute", "logging_retention": "90-day pre-dispute window minimum; permanent verify permalinks", "external_validator": "Nisaba LLC / Velaru", "validator_independence": "Client-side Ed25519 verify; BYOK tri-receipt optional", "headline_stat": "Screening AI failure = criminal liability under Select Agent regulations", "global_leaders_addressed": [ "CDC", "Ginkgo Bioworks", "Twist Bioscience", "NIH", "WHO", "ISO", "NIST", "OECD" ] } MIRROR TRAP (regulatory insight) Cloud lab orders sequence — lab owns biosecurity violation, screening vendor owns API uptime SLA. · Multinationals built for one jurisdiction fail exams in another — one receipt architecture, many filing packs. NERVE CARDS — WHY GLOBAL LEADERS CARE [ { "title": "DURC policy", "body": "Dual use research of concern \u2014 AI screening decision must be documented for IBC review.", "source": "vertical" }, { "title": "Sequence orders", "body": "Every synthesis order needs screening receipt \u2014 HHS 2010 framework now AI-accelerated.", "source": "vertical" }, { "title": "Insurance exclusion", "body": "Biotech policies excluding unscreened AI sequence design.", "source": "vertical" }, { "title": "[Global / Multi-jurisdiction] Jurisdiction shopping ends", "body": "Regulators share examination findings via IAIS, IOSCO, Basel \u2014 governance gap in one market triggers another.", "source": "jurisdiction" }, { "title": "[Global / Multi-jurisdiction] Vendor contract forum", "body": "AI vendor chooses Delaware law \u2014 deployer owns EU, UK, and US state fines simultaneously.", "source": "jurisdiction" }, { "title": "[Text / Chat] Modality hook", "body": "Baseline \u2014 all frameworks apply to text decisions.", "source": "modality" } ] BOOK SUMMARY: { "total_insureds": 0, "compliant": 0, "grace_period": 0, "non_compliant": 0, "expired": 0, "not_enrolled": 0, "compliant_pct": 0.0 } TAM / EXPOSURE: Synthetic biology market $80B+ · DNA synthesis screening mandatory INSURANCE LINES: Biotech E&O, Product liability DISCLAIMER: External validation evidence pack — not legal advice, not filed rate approval.